NCT00543751终止3 期
Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025)
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 入组人数
- 610
研究概览
简要总结
The purpose of this study is to compare how MK0767 and metformin and sulfonylurea therapy lower blood glucose in patients with inadequate glycemic control This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 21 Years 至 78 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with Type 2 diabetes wtih inadequate glycemic control on maximally effective/tolerated metformin and sulfonylurea therapy
- •Non-pregnant females
排除标准
- •Patients with Type 1 Diabetes or history of ketoacidosis
- •Patients who have been treated with insulin or other antihyperglycemic agents
- •Patients with viral hepatitis, active liver or gallbladder disease, history of pancreatitis, heart disease, congestive heart failure, inadequately controlled hypertension, HIV positive, history hematologic disorders or neoplastic disease
研究者
相似试验
终止
3 期
MK0767 and Sulfonylurea Combination Study (0767-027)Diabetes Mellitus, Type 2NCT00543491Merck Sharp & Dohme LLC129
终止
3 期
Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)Diabetes Mellitus, Type 2NCT00543361Merck Sharp & Dohme LLC382
已完成
4 期
Metformin to Prevent Metabolic Complications in Glucocorticoid ExcessPatients With Glucocorticoid TreatmentNCT01187849University Hospital, Basel, Switzerland29
已完成
4 期
Effect of Vildagliptin in Type 2 Diabetes Treated With Sulphonylurea and MetforminDiabetesNCT01099137Seoul National University Bundang Hospital344
终止
4 期
Effects of Metformin and Fish Oil on Treatment With ClozapineSchizo-affective DisorderSchizophreniaNCT02140788Duke University34